Xiaofan Hu, Jing Xu, Wei Wang, Lili Liu, Yuanmeng Jing, Chenni Gao, Xialian Yu, Yi Li, Li Lin, Jun Tong, Qinjie Weng, Xiaoxia Pan, Wen Zhang, Hong Ren, Guisen Li, Krzysztof Kiryluk, Nan Chen, Jingyuan Xie
INTRODUCTION: The aim of this study was to test whether a combined risk score based on genetic risk and serology can improve the prediction of kidney failure in PLA2R-associated primary membranous nephropathy. METHODS: We performed a retrospective analysis of 519 biopsy-proven PLA2R-associated primary membranous nephropathy patients with baseline eGFR ≥ 25ml/min/1.73m2. The combined risk score was calculated by combining the genetic risk score with PLA2R ELISA antibody titers...
February 29, 2024: Clinical Journal of the American Society of Nephrology: CJASN